Dr. Leslie S. Eldeiry, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- University of Miami, Lm Miller School of Medicine (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 497
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: University of Miami, Lm Miller School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
MA license 222194
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
- Umass Memorial Medical Center/university Campus Worcester, MA
- Massachusetts Eye and Ear Infirmary - Boston, MA
Medical groups
- Atrius Health Inc (1,222 clinicians)
- Reliant Medical Group Inc (640 clinicians)
- Massachusetts Eye and Ear Associates, Inc (433 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 497
- Services billed
- 13,322
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 3,420 | 33 |
| Insertion of needle into vein for collection of blood sample | 402 | 258 |
| Blood test, thyroid stimulating hormone (tsh) | 255 | 175 |
| Established patient office or other outpatient visit, 30-39 minutes | 244 | 211 |
| Injection, zoledronic acid, 1 mg | 226 | 44 |
| Magnesium level | 188 | 139 |
| Phosphate level | 177 | 131 |
| Hemoglobin a1c level | 143 | 86 |
| Calcium level, total | 138 | 101 |
| Albumin (protein) level | 132 | 99 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Boston, MA | 549 |
| Ozempic (semaglutide) Other prescribers in Boston, MA | 242 |
| Alendronate Sodium Other prescribers in Boston, MA | 189 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Boston, MA | 154 |
| Jardiance (empagliflozin) Other prescribers in Boston, MA | 138 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Boston, MA | 119 |
| Methimazole Other prescribers in Boston, MA | 95 |
| Mounjaro (tirzepatide) Other prescribers in Boston, MA | 81 |
| Humalog Kwikpen U-100 (insulin lispro) Other prescribers in Boston, MA | 80 |
| Synthroid (levothyroxine sodium) Other prescribers in Boston, MA | 76 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $21.16 in total to this clinician.
| Abbott Laboratories | $21.16 |
|---|
| Food and Beverage | $21.16 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.